Ex-management of Winnipeg cannabis producer hired broker to buy illegal supply: investigator
Bonify sales licence suspension by Health Canada ‘unfounded’; company continues to grow, investigator says
Ex-management of a Winnipeg-based cannabis producer hired a broker to buy what turned out to be illegal product and led Health Canada to pull the company’s sale licence, a third-party investigator says.
George Robinson, who was hired to investigate Bonify Medical Cannabis after two Health Canada product recalls, said three executives, dismissed late last year, used an outside agent to procure illegal cannabis. But Robinson said his review has been unable to verify where the illegal marijuana came from.
Health Canada suspended the sales licence from Winnipeg-based Bonify Medical Cannabis on Monday. A spokesperson said the company was found possessing, distributing and selling product that was purchased from an illegal source.
The company has 10 days to appeal and they intend to do just that. Robinson said previous concerns have already been dealt with.
“We feel that we’ve already met the requirements for the sales licence to be issued, and we will appeal, and appeal with all ferverence, to suggest that we are capable of having our sales license and the suspension is unfounded,” said Robinson, chief executive of RavenQuest Technologies Inc.
A redacted version of a forensic audit of Bonify practices, conducted by RavenQuest, was forwarded to Health Canada, he said.
Though they can’t technically sell at the moment, Robinson said Bonify continues to grow cannabis and will have a full crop ready to sell in March if they get the greenlight to resume sales.
Recalls follow Sask. sales
Health Canada had previously issued a recall notice for two strains of Bonify cannabis sold in Saskatchewan in December. The recall prompted the Liquor, Gaming and Cannabis Authority of Manitoba, which regulates the cannabis retail sector, and the Manitoba Liquor and Lotteries Corporation, the wholesaler of cannabis in the province, to suspend the sale of Bonify products.
In response, the company called for a third-party investigation, led by Robinson, which found the company had sold unauthorized product at retailers in Saskatoon, Regina and Moose Jaw.
Robinson said at the time a closer looked revealed allegations against senior management. They bullied frontline staff into staying quiet when 200 kilograms of unlicensed cannabis arrived at the Winnipeg facility, he said. Three Bonify executives were later dismissed.
Matt Maurer, a lawyer who specializes in cannabis legislation, said the allegation — if true — is “unprecedented.”
“The legal channels have seed-to-sale tracking, so the government can check from basically the time the plant was grown all the way through the process to when it’s sold and trace it back,” he said.
“Effectively what [the allegation] means in really simple terms is that … they got it from someone who’s not licensed to grow, and then they turned around and took it and sold it to the legal market.”
RCMP reviewing case
Health Canada said it passed the case along to RCMP. Tara Seel, a spokesperson for Manitoba RCMP, said the police service is assessing to determine if it will launch a formal investigation.
“The RCMP is presently assisting the province of Manitoba by assessing the information obtained to date with respect to the Bonify matter,” she wrote in an email Wednesday.
“The RCMP continues to conduct a review of this information and will determine the scope of a subsequent investigation, if any, upon completion of the review.”
That doesn’t square with Robinson’s understanding of the situation. He believes the RCMP is conducting a formal investigation, and said former Bonify employees notified the company that members of the RCMP Major Crimes Unit have been interviewing them.
“The reality of it is that that information now is under investigation,” he said.
Bonify is co-operating with RCMP, said RavenQuest.
RavenQuest said it will continue to provide management services to Bonify on a one-year contract, extending the consulting firm’s previous three-month contract with the producer.
Bonify extends contract with RavenQuest
Jeffrey Dyck, chair of Bonify’s board, said the action taken by RavenQuest has been well-received by regulators.
“We’re extremely impressed with the professionalism and expertise with which the RavenQuest team has methodically handled our compliance challenges, and fully expect to resume full cannabis sales activities in the near term with RavenQuest steering our production and quality assurance,” Dyck said in a statement on Wednesday.
“Health Canada has acknowledged the significant progress made inside our facility with respect to quality management systems. Our recent suspension was related to past issues.”
Asked to confirm whether Dyck was aware or involved in the procurement of the illegal cannabis, Robinson would only say another board member was removed and there are no further allegations concerning current board members.
Robinson said the company has demonstrated an “exemplary and spectacular inspection process” and the recent controversy isn’t a reflection on staff.
“What fundamentally changed is a senior management team came in and made some bad choices and forced upon the organization a culture change that now led us up to this point,” he said.